文献速递疼痛医学

脊髓电刺激通过降低脊髓集落刺激因子1水平减轻小胶质细胞活化缓解大鼠慢性压迫性损伤模型中的神经病理性疼痛

Spinal Cord Stimulation Alleviates Neuropathic Pain by Attenuating Microglial Activation via Reducing Colony-Stimulating Factor 1 Levels in the Spinal Cord in a Rat Model of Chronic Constriction Injury.
PubMed 文献 · Anesth Analg · 2022-04-04

该研究在大鼠慢性压迫性损伤(CCI)模型中验证脊髓电刺激(SCS)是否通过阻断集落刺激因子1(CSF1)减轻脊髓小胶质细胞活化来缓解神经病理性疼痛。结果显示SCS显著提高机械缩足阈值并减轻脊髓背角小胶质细胞活化,伴随脊髓背角和背根CSF1水平下降;鞘内注射CSF1完全逆转SCS的镇痛效应和小胶质细胞活化改变。结论认为SCS至少部分通过抑制损伤侧背根神经节释放CSF1来减轻脊髓小胶质细胞活化并缓解慢性神经病理性疼痛。

要点

  • SCS可提高CCI大鼠机械缩足阈值并减轻脊髓背角小胶质细胞活化。
  • SCS降低脊髓背角和背根CSF1水平,但不降低背根神经节CSF1水平。
  • 鞘内注射CSF1完全消除SCS的镇痛效应和小胶质细胞活化改变。

核心结论

  • SCS减轻脊髓小胶质细胞活化并缓解慢性神经病理性疼痛,至少部分通过抑制损伤侧背根神经节释放CSF1实现。

研究设计与样本

  • Sprague-Dawley大鼠行坐骨神经结扎诱导CCI并植入硬膜外SCS电极。
  • SCS每天6小时、连续5天;部分大鼠在SCS期间每天鞘内注射CSF1、连续3天。
  • 采用免疫荧光或Western blotting检测小胶质细胞活化和CSF1水平。

主要发现

  • 与正常大鼠相比,CCI大鼠机械缩足阈值显著降低,脊髓背角和背根神经节小胶质细胞活化增加、CSF1水平升高。
  • SCS显著提高CCI大鼠机械缩足阈值并减轻脊髓背角小胶质细胞活化,伴随脊髓背角和背根CSF1水平下降,但背根神经节CSF1水平未下降。
  • 鞘内注射CSF1完全消除SCS引起的CCI大鼠机械缩足阈值变化和脊髓背角小胶质细胞活化改变。

临床怎么用

  • 该大鼠模型提示SCS镇痛机制与抑制背根神经节CSF1释放、减轻脊髓小胶质细胞活化相关。
  • CSF1-小胶质细胞轴可作为神经病理性疼痛SCS治疗的潜在机制靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spinal cord stimulation (SCS) is an emerging, minimally invasive procedure used to treat patients with intractable chronic pain conditions. Although several signaling pathways have been proposed to account for SCS-mediated pain relief, the precise mechanisms remain poorly understood. Recent evidence reveals that injured sensory neuron-derived colony-stimulating factor 1 (CSF1) induces microglial activation in the spinal cord, contributing to the development of neuropathic pain (NP). Here, we tested the hypothesis that SCS relieves pain in a rat model of chronic constriction injury (CCI) by attenuating microglial activation via blocking CSF1 to the spinal cord. METHODS: Sprague-Dawley rats underwent sciatic nerve ligation to induce CCI and were implanted with an epidural SCS lead. SCS was delivered 6 hours per day for 5 days. Some rats received a once-daily intrathecal injection of CSF1 for 3 days during SCS. RESULTS: Compared with naive rats, CCI rats had a marked decrease in the mechanical withdrawal threshold of the paw, along with increased microglial activation and augmented CSF1 levels in the spinal dorsal horn and dorsal root ganglion, as measured by immunofluorescence or Western blotting. SCS significantly increased the mechanical withdrawal threshold and attenuated microglial activation in the spinal dorsal horn in CCI rats, which were associated with reductions in CSF1 levels in the spinal dorsal horn and dorsal roots but not dorsal root ganglion. Moreover, intrathecal injection of CSF1 completely abolished SCS-induced changes in the mechanical withdrawal threshold and activation of microglia in the spinal dorsal horn in CCI rats. CONCLUSIONS: SCS reduces microglial activation in the spinal cord and alleviates chronic NP, at least in part by inhibiting the release of CSF1 from the dorsal root ganglion ipsilateral to nerve injury.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Sun C, Tao X, Wan C, et al. Spinal Cord Stimulation Alleviates Neuropathic Pain by Attenuating Microglial Activation via Reducing Colony-Stimulating Factor 1 Levels in the Spinal Cord in a Rat Model of Chronic Constriction Injury. Anesth Analg. 2022. PMID: 35709447. doi:10.1213/ANE.0000000000006016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。